Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties
about
Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivoInhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsaminaTargeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin.A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA.Epidermal growth factor receptor downregulation by small heterodimeric binding proteinsPhotochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer.Delivery of antibody mimics into mammalian cells via anthrax toxin protective antigenA Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of DoxorubicinDevelopment and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells.Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.Antibody-mediated neutralization of perfringolysin o for intracellular protein delivery.Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin.Designing immunoconjugates for cancer therapy.Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.Photochemical activation of drugs for the treatment of therapy-resistant cancers.Geometry and expression enhance enrichment of functional yeast-displayed ligands via cell panning.Improved Synthesis and In Vitro Evaluation of an Aptamer Ribosomal Toxin Conjugate.Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy.α-sarcin and RNase T1 based immunoconjugates: the role of intracellular trafficking in cytotoxic efficiency.A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor.Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticlesIn vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin.The toxin component of targeted anti-tumor toxins determines their efficacy increase by saponins.Development and validation of an enzyme-linked immunosorbent assay for the quantification of gelonin in mouse plasma.Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cells.A mechanistic compartmental model for total antibody uptake in tumors.Improved Protein Toxin Delivery Based on ATTEMPTS Systems.The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations.Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers.Preparation of an engineered safer immunotoxin against colon carcinoma based on the ribotoxin hirsutellin A.VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells.Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding.Modular pore-forming immunotoxins with caged cytotoxicity tailored by directed evolutionA Long Journey to the Cytosol
P2860
Q27314650-861390B7-2D9D-4B3A-984E-E7F83819232BQ28536744-93CE8579-E276-4BC5-8FE5-EC3D0ABA4D69Q33647683-16A8275E-1153-4F5A-A0E6-A645478C369AQ33701022-110BF370-07EE-4438-8197-BE31CB88652FQ34097126-AEBF5A5A-E262-4854-AB0C-CC95B8BD9643Q35828597-4E790837-3D7A-47A3-9180-6CF653ACE64EQ35838335-5C9E105C-91FB-4209-9BE8-78041BD987E8Q36446685-676478BC-31BB-454D-9FE7-88E104F66427Q36469716-CDAFB3FB-45AC-4C4A-BF53-2B237C7350FEQ36791673-AE16C4E2-DD91-4674-ADB3-0416DF4C338AQ36926959-391B4DD3-D9F0-4D33-AB0B-7A05D1A4B67EQ37698916-F0F84B3B-0D1D-4645-9EF3-E83F25BF51F1Q38017203-6CD82C7A-3C90-47CB-9E40-F7427CE5BEA5Q38262399-918F1838-ED9B-4A93-A713-90541AB544F7Q38409528-DD626B27-6ABC-47C8-916C-D5677C2DBA67Q38773272-BC596290-74A5-44B9-AF05-D0F99A7218A6Q38862110-8C36E74F-3FED-48E0-847E-6EB107EF2C77Q38909313-600CDA07-3E03-4837-B54F-E2E2E08B4AA5Q38932236-F5B81778-9813-4B42-9606-92456B83ADC6Q38949177-AFB5305A-7A85-46E8-ACDE-F554E1BF0CBAQ39146031-65317F95-B2B0-4B32-9780-4562A558BD6BQ39187821-42583539-1B59-4734-8F85-578BF55187E4Q39385032-8AA9B0BA-16C5-4AEF-983F-2A5A07363B4AQ39656007-197D51A0-AB44-4BAF-9125-2D84DBB307FCQ39803785-0BA13C42-883E-4ED4-8207-4C0A94102D9BQ40267233-103F6480-DBD3-488C-AB8C-D8658A5AF7D4Q43066289-3FF0188B-EFF9-411F-89D4-54C1899F28B2Q46409297-FC49CB35-CCF1-411E-A1D6-AF8F75DD6995Q47231221-A0D074CF-6B96-452A-A09C-47A835F24DD6Q52676610-960ABF8C-70B9-42A3-AED7-719500E103D7Q53296795-70953371-B495-4E93-BC60-0B363118194AQ55129555-58CD79AF-7FC2-4A96-9560-2A31DDA9B4E0Q55257427-9748BFE4-D530-4B98-89F0-16963F68D113Q56872060-28658796-1985-43EC-A2F3-E742DE72D1AFQ58236941-5A2EE835-5D92-47AE-A6C2-ADB842780052
P2860
Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Convergent potency of internal ...... tigens, and targeting moieties
@ast
Convergent potency of internal ...... tigens, and targeting moieties
@en
Convergent potency of internal ...... tigens, and targeting moieties
@nl
type
label
Convergent potency of internal ...... tigens, and targeting moieties
@ast
Convergent potency of internal ...... tigens, and targeting moieties
@en
Convergent potency of internal ...... tigens, and targeting moieties
@nl
prefLabel
Convergent potency of internal ...... tigens, and targeting moieties
@ast
Convergent potency of internal ...... tigens, and targeting moieties
@en
Convergent potency of internal ...... tigens, and targeting moieties
@nl
P2093
P2860
P356
P1476
Convergent potency of internal ...... tigens, and targeting moieties
@en
P2093
Benjamin J Hackel
Christopher M Pirie
K Dane Wittrup
Michael G Rosenblum
P2860
P304
P356
10.1074/JBC.M110.186973
P407
P577
2010-12-07T00:00:00Z